Biogen Inc (BIIB)

Debt-to-assets ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	4,547,200	—	—	—	6,788,200	—	—	—	6,567,300	—	—	—	7,567,300	—	—	—	7,500,000	—	—	—
Total assets	US$ in thousands	28,049,300	28,313,200	26,804,100	26,567,600	26,844,800	28,193,200	25,156,800	24,598,400	24,554,100	24,854,200	25,081,400	23,614,400	23,877,300	23,806,700	24,470,400	23,854,700	24,618,900	24,934,100	25,511,800	26,119,200
Debt-to-assets ratio		0.16	0.00	0.00	0.00	0.25	0.00	0.00	0.00	0.27	0.00	0.00	0.00	0.32	0.00	0.00	0.00	0.30	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $4,547,200K ÷ $28,049,300K
= 0.16

The debt-to-assets ratio of Biogen Inc has shown a relatively stable trend over the past few years, with values fluctuating between 0.00 and 0.32. The ratio measures the proportion of the company's total debt compared to its total assets. A lower ratio indicates that the company relies less on debt financing to fund its operations and has a stronger financial position.

The ratio was highest at 0.32 at the end of December 31, 2021, suggesting a moderate level of debt relative to assets at that time. It then decreased to 0.16 by December 31, 2024, indicating a lower reliance on debt financing. The consistent values of 0.00 for certain quarters may indicate periods where the company had no debt on its balance sheet.

Overall, Biogen Inc's debt-to-assets ratio reflects a conservative approach to debt management, with a focus on maintaining a healthy balance between debt and assets to support its financial stability and growth objectives.